Jeffrey Dage

Indiana University Indianapolis

$4,494,717

Attributed

$4,494,717

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $7.1M · FY2024–25

$10M$7.5M$5M$2.5M$0

'24

'25

Funding mix

By agency

NIH$7,829,733 · 3

By mechanism

U54$6,328,480 · 2

R01$1,501,253 · 1

Top collaborators

Most similar at Indiana University Indianapolis

Same institution · by research overlap

Sara K Quinney$11,876,528
Paul Richard Territo$22,416,914
Adrian Lynn Oblak$5,075,046
Li Shen$13,717,828
Dokyoon Kim$5,147,076

Others in their field

Other Rising Stars on “Alzheimer&Apos”

Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
Yanling Wang · Rush University Medical Center$2,986,919
William G Mantyh · University Of Minnesota$2,961,521
Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
Noah Ray Johnson · University Of Colorado Denver$2,282,487

Research focus

Alzheimer&AposEvaluationDoseResourcesS DiseaseRecommendationAssay DevelopmentSuccessPre-ClinicalPathologySamplingS Disease Related DementiaTissuesAmyloid Beta-ProteinClinical TrialsBiobankFutureBiological MarkersScreeningBrainBindingAutopsyAccelerationAlzheimerâS Disease Biomarker

Grant awards (4)

Microphysiological systems to Advance Precision medicine for Alzheimer's Disease and Related Dementias (MAP-AD)$3,335,016

U54 · FY2025 · AG

Assay Development and High Throughput Screening (ADHTS) Core$2,993,464

U54 · FY2025 · AG · contact PI

Discovery of novel tau proteoforms as biomarker candidates for AD and PSP$754,586

R01 · FY2025 · AG · contact PI

Discovery of novel tau proteoforms as biomarker candidates for AD and PSP$746,667

R01 · FY2024 · AG · contact PI